| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 966 |
| 1 | ETANERCEPT | 917 |
| 2 | ADALIMUMAB | 914 |
| 3 | METHOTREXATE | 866 |
| 4 | TOCILIZUMAB | 607 |
| 5 | INFLIXIMAB | 511 |
| 6 | ABATACEPT | 474 |
| 7 | ADALIMUMAB-ADAZ | 470 |
| 8 | PREDNISONE | 462 |
| 9 | ADALIMUMAB-AATY | 459 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIAMCINOLONE HEXACETONIDE | 139 | 0.5305 |
| 1 | TETANUS IMMUNE GLOBULIN (HUMAN) | 16 | 0.1468 |
| 2 | DICLOFENAC SODIUM/MISOPROSTOL | 12 | 0.0271 |
| 3 | ANAKINRA | 372 | 0.0220 |
| 4 | CANAKINUMAB | 156 | 0.0143 |
| 5 | SILTUXIMAB | 7 | 0.0108 |
| 6 | ADALIMUMAB-FKJP | 455 | 0.0099 |
| 7 | ADALIMUMAB-AATY | 459 | 0.0092 |
| 8 | ADALIMUMAB-ADAZ | 470 | 0.0085 |
| 9 | GOLIMUMAB | 102 | 0.0081 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 1425 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 863 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 615 |
| 3 | Corticosteroid [EPC] | 602 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 566 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 474 |
| 6 | Aminosalicylate [EPC] | 388 |
| 7 | Interleukin-1 Receptor Antagonist [EPC] | 372 |
| 8 | Vitamin C [EPC] | 275 |
| 9 | Vitamin B12 [EPC] | 218 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 372 | 0.0220 |
| 1 | Interleukin-6 Antagonist [EPC] | 7 | 0.0108 |
| 2 | Human Immunoglobulin G [EPC] | 105 | 0.0050 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 615 | 0.0044 |
| 4 | Provitamin D2 Compound [EPC] | 125 | 0.0042 |
| 5 | Aminosalicylate [EPC] | 388 | 0.0039 |
| 6 | Stimulant Laxative [EPC] | 55 | 0.0038 |
| 7 | Prostaglandin E1 Analog [EPC] | 60 | 0.0036 |
| 8 | Selective T Cell Costimulation Modulator [EPC] | 474 | 0.0034 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 863 | 0.0020 |